Zevra Therapeutics (ZVRA) Current Leases (2016 - 2025)
Historic Current Leases for Zevra Therapeutics (ZVRA) over the last 11 years, with Q3 2025 value amounting to $441000.0.
- Zevra Therapeutics' Current Leases fell 1833.33% to $441000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $441000.0, marking a year-over-year decrease of 1833.33%. This contributed to the annual value of $420000.0 for FY2024, which is 2265.19% down from last year.
- Zevra Therapeutics' Current Leases amounted to $441000.0 in Q3 2025, which was down 1833.33% from $525000.0 recorded in Q2 2025.
- Zevra Therapeutics' Current Leases' 5-year high stood at $596000.0 during Q2 2024, with a 5-year trough of $336000.0 in Q1 2021.
- In the last 5 years, Zevra Therapeutics' Current Leases had a median value of $463000.0 in 2023 and averaged $460500.0.
- Its Current Leases has fluctuated over the past 5 years, first soared by 3581.66% in 2022, then plummeted by 2265.19% in 2024.
- Quarter analysis of 5 years shows Zevra Therapeutics' Current Leases stood at $356000.0 in 2021, then soared by 34.83% to $480000.0 in 2022, then rose by 13.12% to $543000.0 in 2023, then fell by 22.65% to $420000.0 in 2024, then increased by 5.0% to $441000.0 in 2025.
- Its last three reported values are $441000.0 in Q3 2025, $525000.0 for Q2 2025, and $589000.0 during Q1 2025.